Robert Roe interviews MathWorks Loren Dean, on the use of AI in modelling and simulation
Gemma Church investigates how simulation and modelling are helping expedite the development of cutting-edge medical devices
Christian Marcazzo, general manager at IDBS, highlights trends in life sciences research and development.
Correct storage and use of data is the key to keeping data ‘current’ and relevant in modern laboratories, writes Sophia Ktori
Robert Roe interviews Mark Parsons on the strategy for HPC in the UK
Rob Lalonde, Univa’s cloud VP general manager, considers the unique challenges posed by HPC
Robert Roe looks at the development of deep learning and its impact on scientific applications
As cloud technology matures, the options for HPC users continue to expand, writes Robert Roe
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
